Galderma Investigational Site 8255

Philadelphia, Pennsylvania 19103-4708

0 studies enrolling now · 4 studies all time

What they study most

Chronic Pruritus of Unknown Origin, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) — Running, not enrolling
• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed